Increased insulin is not required for beta2-adrenoceptor-induced increases in mouse brain tryptophan.
The current study tested the hypothesis that beta(2)-adrenoceptor-mediated increases in brain tryptophan are caused by increased insulin secretion. Male mice were treated with streptozotocin (40 mg/kg) for 5 days to induce experimental diabetes. Control and diabetic mice were treated with the beta(2)-adrenoceptor agonist, clenbuterol (0.1 mg/kg), 1 h before selected brain regions were dissected for analysis by high performance liquid chromatography (HPLC) with electrochemical detection for tryptophan content, and plasma was collected for analysis of total and free tryptophan and glucose concentrations. Clenbuterol increased brain tryptophan and plasma glucose and decreased plasma total tryptophan but did not alter plasma free tryptophan. There were no significant differences in brain or plasma tryptophan between control and streptozotocin-treated mice. In a separate experiment, pretreatment of the mice with an insulin antibody did not prevent the clenbuterol-induced increases in brain tryptophan. These results suggest that beta(2)-adrenoceptor agonists increase brain tryptophan by a mechanism that does not involve changes in insulin.
Department of Pharmacology and Therapeutics and School of Graduate Studies, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, USA. nlenar@lsuhsc.edu
Natalie R
NR
Lenard
Adrian J
AJ
Dunn
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D001786:Blood Glucose; D001921:Brain / Q000378:metabolism*; D002851:Chromatography, High Pressure Liquid; D002976:Clenbuterol / Q000008:administration & dosage / Q000494:pharmacology; D003921:Diabetes Mellitus, Experimental / Q000378:metabolism; D004305:Dose-Response Relationship, Drug; D007328:Insulin / Q000378:metabolism*; D007330:Insulin Antibodies / Q000494:pharmacology; D008297:Male; D051379:Mice; D018343:Receptors, Adrenergic, beta-2 / Q000502:physiology*; D014364:Tryptophan / Q000097:blood / Q000378:metabolism*
D058666:Adrenergic beta-2 Receptor Agonists; D000318:Adrenergic beta-Agonists; D001786:Blood Glucose; D007328:Insulin; D007330:Insulin Antibodies; D018343:Receptors, Adrenergic, beta-2; D014364:Tryptophan; D002976:Clenbuterol